Congressional Research Service. October 29, 2014.
The United States is the leading funder of the international Ebola response, and its financial support is growing. While deliberating the appropriate response to ongoing Ebola outbreak, Congress is likely to discuss the breadth of health, social, economic, development, and security challenges that this outbreak is causing, as well as how U.S. global health aid is apportioned. This report focuses on the health impacts of the outbreak and discusses U.S. and international responses to those health challenges.
http://fpc.state.gov/documents/organization/234357.pdf [PDF format, 30 pages].
Center for Strategic & International Studies. October 8, 2014.
President Obama recently announced that the Department of Defense (DoD) would deploy 3,000 troops to lead a major expansion of the U.S. response to Ebola. This campaign will amplify efforts that already include the largest international response by the Centers for Disease Control and Prevention in its history, numerous other U.S. agencies, and a large coalition of international partners assisting the affected nations. [Note: contains copyrighted material].
http://csis.org/files/publication/140930_Daniel_DODGlobalHealth_Web.pdf [PDF format, 20 pages].
Congressional Research Service. October 3, 2014.
This report discusses Ebola virus disease (EVD) in general, including symptoms, modes of transmission, incubation period, and treatments; presents projections of the future course of the outbreak; and lists additional CRS products, including products focused on the situation in West Africa. Unless otherwise cited, information in this report is drawn from Ebola information pages of the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
http://fas.org/sgp/crs/misc/R43750.pdf [PDF format, 6 pages].
YaleGlobal. September 18, 2014.
Ebola is spreading quickly in West Africa and, with global air travel, could quickly hop new borders. The health infrastructure of West Africa is weak, with limited resources and trained personnel. Prevention is the goal for a virus with no approved vaccine or therapeutic. Funding is scarce, even for premier researchers with the World Health Organization and the U.S. Centers for Disease Control. Nations with advanced health systems could take the lead by imposing a small tax on international air tickets, argues the author. A $3 tax could raise $500 million per year, funding research and development for vaccines, therapeutics or diagnostics for Ebola and other emerging infectious diseases. Infectious diseases leave behind a trail of death and economic harm, and a massive, well-funded response is in the interest of all. [Note: contains copyrighted material].
http://yaleglobal.yale.edu/content/how-fund-ebola-fight [HTML format].
Congressional Research Service. August 26, 2014.
In July 2014, two U.S. citizen health workers contracted Ebola in Liberia and were first provided medication that had shown promise in animal studies but that had not yet been tested in humans. They were evacuated to the United States to receive additional care. Debate in the United States has ensued regarding entry and exit rights of people infected with communicable diseases; whether the international community (including the United States) had responded early and effectively enough to contain the virus; the appropriate use of experimental drugs that had not yet been tested for human safety and effectiveness, including how to choose recipients of scarce and sometimes costly drug supplies and how to arrange dispensing to allow analysis of safety and effectiveness; and feasible approaches to accelerating drug and vaccine development and the scale-up of manufacturing capacity for investigational products.
http://fas.org/sgp/crs/row/R43697.pdf [PDF format, 26 pages].